Chemomab Therapeutics Ltd. (CMMB)
↓ Download CSVKey ratios (FY2025)
-72.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | $2.33M | $2.46M | $4.39M | $5.14M | $3.31M | — | — | — | — |
| Operating Income | -$112.00M | -$103.00M | — | — | — | — | — | — | — |
| Net Income | -$8.99M | -$13.95M | -$24.22M | -$27.65M | -$12.48M | -$5.95M | -$27.12M | -$13.80M | — |
| EPS (Diluted) | $0.02 | $0.04 | $0.10 | $0.12 | $0.06 | — | — | — | — |
| Total Assets | $13.81M | $16.96M | $22.15M | $43.06M | $64.35M | $12.48M | $19.75M | $12.76M | — |
| Total Liabilities | $1.48M | $3.43M | $5.15M | $6.84M | $2.89M | $1.67M | $4.85M | $2.96M | — |
| Shareholders' Equity | $12.33M | $13.54M | $17.00M | $36.22M | $61.47M | $10.80M | $12.37M | $9.80M | -$609.0K |
| Cash & Equivalents | $7.56M | $6.07M | $9.29M | $13.52M | $15.19M | $11.67M | $17.57M | $7.52M | — |
| Operating Cash Flow | -$11.13M | -$15.39M | -$23.61M | -$20.37M | -$12.37M | -$5.24M | -$16.46M | -$14.22M | — |
| Capital Expenditures | $3.0K | $0 | $3.0K | $68.0K | $239.0K | $38.0K | $95.0K | $213.0K | — |
| Shares Outstanding | 510.23M | 359.05M | 235.00M | 227.59M | 207.47M | — | — | — | — |